AU4941096A - Self-deleting vectors for gene therapy - Google Patents

Self-deleting vectors for gene therapy

Info

Publication number
AU4941096A
AU4941096A AU49410/96A AU4941096A AU4941096A AU 4941096 A AU4941096 A AU 4941096A AU 49410/96 A AU49410/96 A AU 49410/96A AU 4941096 A AU4941096 A AU 4941096A AU 4941096 A AU4941096 A AU 4941096A
Authority
AU
Australia
Prior art keywords
self
gene therapy
deleting
vectors
deleting vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49410/96A
Inventor
Manuel Grez
Andreas Peter Russ
Harald Von Melchner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU4941096A publication Critical patent/AU4941096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU49410/96A 1995-08-18 1996-02-23 Self-deleting vectors for gene therapy Abandoned AU4941096A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19530412 1995-08-18
DE1995130412 DE19530412A1 (en) 1995-08-18 1995-08-18 Self-deleting retroviral vectors for gene therapy
PCT/EP1996/000761 WO1997007223A1 (en) 1995-08-18 1996-02-23 Self-deleting vectors for gene therapy

Publications (1)

Publication Number Publication Date
AU4941096A true AU4941096A (en) 1997-03-12

Family

ID=7769797

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49410/96A Abandoned AU4941096A (en) 1995-08-18 1996-02-23 Self-deleting vectors for gene therapy

Country Status (5)

Country Link
EP (1) EP0845041A1 (en)
JP (1) JPH11511018A (en)
AU (1) AU4941096A (en)
DE (1) DE19530412A1 (en)
WO (1) WO1997007223A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN903196A0 (en) * 1996-03-29 1996-04-26 Australian National University, The Single-step excision means
GB9810423D0 (en) * 1998-05-15 1998-07-15 Cancer Res Campaign Tech Ionizing radiation or diathermy-switched gene therapy vectors and their use in antitumour therapy
DE19834430C2 (en) 1998-07-30 2000-05-31 Harald Von Melchner Self-deleting vectors for cancer therapy
AU4315000A (en) * 1999-06-04 2000-12-28 Nippon Institute For Biological Science Novel plasmid vector
DE19941186A1 (en) * 1999-08-30 2001-03-01 Peter Droege Sequence-specific DNA recombination in eukaryotic cells
US6852530B2 (en) 2000-04-12 2005-02-08 Dana Farber Cancer Institute, Inc. Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300422B1 (en) * 1987-07-21 1992-12-02 The Du Pont Merck Pharmaceutical Company An improved method for preparing stable and viable recombinant animal cell viral vectors
US5527695A (en) * 1993-01-29 1996-06-18 Purdue Research Foundation Controlled modification of eukaryotic genomes
JP4216350B2 (en) * 1994-09-19 2009-01-28 大日本住友製薬株式会社 Recombinant DNA viral vector for animal cell infection

Also Published As

Publication number Publication date
DE19530412A1 (en) 1997-02-20
WO1997007223A1 (en) 1997-02-27
JPH11511018A (en) 1999-09-28
EP0845041A1 (en) 1998-06-03

Similar Documents

Publication Publication Date Title
AU699706C (en) Improved vectors for gene therapy
AU5153296A (en) Vectors for gene delivery
AU2552795A (en) Safe vectors for gene therapy
AU4787697A (en) Therapeutic gene
AU5671696A (en) Scytalidium catalase gene
AU5586398A (en) Submersive therapy apparatus
AU5638496A (en) Viral vectors
AU7019494A (en) Genetic therapy for cardiovascular disease
AU5723696A (en) Gene therapy using replication competent targeted adenoviral vectors
AU690034B2 (en) Sequence controller
AU6014094A (en) Episomal vectors for gene therapy
AU5268696A (en) Novel compounds and methods for therapy
AU3169495A (en) Gene therapy for restenosis using an adenoviral vector
IL117713A0 (en) Gene expression system
AU5315796A (en) Mammalian expression vectors
EP0739983A3 (en) Gene encoding lacto-n-biosidase
AU4401297A (en) Improved retroviral vectors for gene therapy
AU4941096A (en) Self-deleting vectors for gene therapy
AU2611695A (en) Sailboatsystem for controlled gibing
GB9506051D0 (en) Gene expression
AU7936898A (en) Vectors for treating cancer
AU3036197A (en) Adenovirus vectors for gene therapy
AU5135396A (en) Biosynthetic virus vectors for gene therapy
AU4649396A (en) Gene transduction system
AU7504196A (en) Body support